Completed PHASE2 INTERVENTIONAL 3-arm NCT02680977

Mucuna Pruriens Therapy in Parkinson's Disease

Mucuna Pruriens Therapy in Parkinson's Disease: a Double-blind, Placebo-controlled, Randomized, Crossover Study.

Sponsor: ASST Gaetano Pini-CTO

Interventions LD+DDCI LD-DDCI MP+DDCI MP-Equivalent MP-Low Placebo

Updated 6 times since 2017 Last updated: Oct 4, 2016 Started: Feb 29, 2016 Primary completion: May 31, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Parkinson's Disease and is currently completed. ASST Gaetano Pini-CTO leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Feb 2019 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Feb 2019 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ASST Gaetano Pini-CTO
Grisons Foundation for Parkinson's Disease

Data source: ASST Gaetano Pini-CTO

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santa Cruz de la Sierra, Bolivia